Drug Trial Radar · NCT07626411
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
15,364
Planned (sponsor's estimate)
Start
Aug 10, 2026
Primary completion
Sep 11, 2029
Study completion Dec 10, 2029
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Jun 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called apixaban. The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. The aim of the study is to see how safe and effective REGN7508 is in preventing stroke and/or systemic embolism in participants with atrial fibrillation and how it compares against participants that will receive apixaban in this study. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)
Conditions
- Atrial Fibrillation (AF)
Interventions
REGN7508Drug
Administered per the protocol
ApixabanDrug
Administered per the protocol
PlaceboDrug
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first occurrence of stroke (ischemic, hemorrhagic, or of unspecified type) or systemic embolismTime frame: Approximately 36 months
- Time to first occurrence of International Society on Thrombosis and Haemostasis (ISTH) major bleeding or ISTH Clinically Relevant Non-Major (CRNM) bleedingTime frame: Approximately 36 months
Locations
84 sites in 3 countries. Site status is shown where the registry gives one.
Advanced Cardiovascular
Alexander City, Alabama · Recruiting
SEC Clinical Research
Dothan, Alabama · Recruiting
Eastern Shore Research Institute
Fairhope, Alabama · Recruiting
West Valley Clinical Trials
Glendale, Arizona · Recruiting
Scottsdale Clinical Trials
Scottsdale, Arizona · Recruiting
Arkansas Cardiology P.A.
Little Rock, Arkansas · Recruiting
Valley Clinical Trials, Inc
Covina, California · Recruiting
Mission Cardiovascular Research Institute
Fremont, California · Recruiting
National Institute of California Heart and Vein Specialists
Huntington Beach, California · Recruiting
Alliance Clinical Los Angeles
Inglewood, California · Recruiting
Profound Research LLC at San Diego Cardiovascular Associates
La Jolla, California · Recruiting
Radin Cardiovascular Medical Group
Newport Beach, California · Recruiting
Valley Clinical Trials, LLC dba Flourish Research
Northridge, California · Recruiting
Southern California Heart Specialists
Pasadena, California · Recruiting
The Cardiovascular Center
Redding, California · Recruiting
FOMAT - Comprehensive Cardiovascular Care
Santa Maria, California · Recruiting
Cardiology Associates Medical Group
Ventura, California · Recruiting
Interventional Cardiology Medical Group
West Hills, California · Recruiting
Excel Medical Clinical Trials, dba Flourish Research
Boca Raton, Florida · Recruiting
Nouvelle Clinical Research LLC
Cutler Bay, Florida · Recruiting
Nature Coast Clinical Research - Inverness
Inverness, Florida · Recruiting
East Coast Institute for Research, Jacksonville
Jacksonville, Florida · Recruiting
South Florida Research Organization LLC
Medley, Florida · Recruiting
Novera Clinical Research
Miami, Florida · Recruiting
Healix Clinical Research
New Smyrna Beach, Florida · Recruiting
Sec Clinical Research
Pensacola, Florida · Recruiting
East Coast Institute for Research, St. Augustine
Saint Augustine, Florida · Recruiting
Flourish Research, St. Johns Center for Clinical Research
Saint Augustine, Florida · Recruiting
Cardiovascular Center of Sarasota Foundation for Research and Education
Sarasota, Florida · Recruiting
Clinical Site Partners, LLC DBA Flourish Research
Winter Park, Florida · Recruiting
Morehouse School Of Medicine
Atlanta, Georgia · Recruiting
Atlanta Clinical Research Centers
Atlanta, Georgia · Recruiting
NSC Research, Inc
Johns Creek, Georgia · Recruiting
Profound Research, Advanced Cardiovascular Care + Electrophysiology Clinic
Hobart, Indiana · Recruiting
Franciscan Physician Network, Indiana Heart Physicians
Indianapolis, Indiana · Recruiting
Cardiovascular Research of Northwest Indiana, LLC
Munster, Indiana · Recruiting
Profound Research, Powers Health Medical Group - Electrophysiology
Munster, Indiana · Recruiting
Monroe Research, LLC
West Monroe, Louisiana · Recruiting
Anderson Medical Research
Ft. Washington, Maryland · Recruiting
K2 Medical Research, Foxboro
Foxborough, Massachusetts · Recruiting
Showing 40 of 84 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.